Study to Evaluate HT-6184 in Healthy Subjects

NCT05447546 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Healthy Subjects

Interventions

DRUG: HT-6184
DRUG: HT-6184 Placebo

Sponsor

Halia Therapeutics, Inc.

Collaborators

[object Object]